Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elaina V. Preston"'
Autor:
Karthik Nath, Jasme Lee, Theresa A. Elko, Lauren Levy, Elaina V. Preston, Sean M. Devlin, Doris M. Ponce, Dr. Richard J. Lin, Brian C. Shaffer, Christina Cho, Ioannis Politikos, Ann A. Jakubowski, Jae H. Park, Raajit Rampal, Miguel-Angel Perales, Martin Tallman, Juliet N. Barker, Sergio A Giralt, Ellin Berman, Roni Tamari, Eytan Stein, Boglarka Gyurkocza
Publikováno v:
Blood. 140:2137-2139
Autor:
Michael Scordo, Gunjan L. Shah, Peter A. Adintori, Andrea Knezevic, Sean M. Devlin, Marissa L. Buchan, Elaina V. Preston, Andrew P. Lin, Natasia T. Rodriguez, Caroline A. Carino, Linh K. Nguyen, Nancy Cruz Sitner, Andrei Barasch, Mark G. Klang, Molly A. Maloy, Brooke Mastrogiacomo, Dean C. Carlow, Ryan C. Schofield, Ann E. Slingerland, John B. Slingerland, Christoph K. Stein‐Thoeringer, Oscar B. Lahoud, Heather J. Landau, David J. Chung, Marcel R.M. van den Brink, Jonathan U. Peled, Sergio A. Giralt
Publikováno v:
Cancer
Dysgeusia is a common but understudied complication in patients undergoing autologous hematopoietic cell transplantation (auto-HCT). We assessed the feasibility of using chemical gustometry (CG) to measure dysgeusia and explored its associations with
Autor:
Marissa L. Buchan, Jonathan U. Peled, Michael Scordo, Joel B. Epstein, Gunjan L. Shah, Andrei Barasch, Sergio Giralt, Elaina V. Preston
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:425-432
Dysgeusia is a frequently encountered symptom for patients after hematopoietic cell transplantation that has important long-term effects on physical, nutritional, and immunologic recovery as well as quality of life. Despite the relevance of this symp
Autor:
Marcel R.M. van den Brink, Dean Carlow, Ann E. Slingerland, Gunjan L. Shah, Heather Landau, Sean M. Devlin, Ryan Schofield, Michael Scordo, Andrea Knezevic, Natasia Rodriguez, Jonathan U. Peled, Andrew Lin, David J. Chung, Caroline A. Carino, Marissa L. Buchan, Sergio Giralt, Christoph K. Stein-Thoeringer, Liliya Kalendareva, Elaina V. Preston, Molly Maloy
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S158-S159
Introduction Dysgeusia commonly influences nutritional intake and quality of life after HCT, yet its pathobiology is poorly understood and methods to study it are not established. We report interim results of a prospective feasibility study of chemic
Autor:
Florent Malard, Molly Maloy, Katherine Smith, Sean M. Devlin, Taylor Borrill, Kenneth Seier, Meighan Palazzo, Christina Cho, Elaina V. Preston, Marcel R.M. van den Brink, Miguel-Angel Perales, Gunjan L. Shah, Peter Maslak
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S427-S428
Autor:
Caitlin Sarubbi, Poguang Wang, David J. Chung, Dean Carlow, Heather Landau, Valkal Bhatt, Gunjan L. Shah, Sean M. Devlin, Ryan Schofield, Parastoo B. Dahi, Roger W. Giese, Elizabeth Hoover, Guenther Koehne, Andrew Lin, Roni Tamari, Stephen Harnicar, Sergio Giralt, Elaina V. Preston
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S129-S130
Autor:
Kenneth Seier, Craig S. Sauter, Gunjan L. Shah, Craig H. Moskowitz, Sean M. Devlin, Matthew J. Matasar, Parastoo B. Dahi, Miguel-Angel Perales, Sergio Giralt, Elaina V. Preston, Meighan Palazzo, Michael Scordo
Publikováno v:
Blood. 132:4592-4592
Background: Guidelines recommend reimmunization starting 12 months after autologous hematopoietic stem cell transplant (AHCT). However, lymphoma patients routinely receive rituximab, an anti-CD20 monoclonal antibody that depletes CD20+ B-cells and ma
Autor:
Natasia Rodriguez, Jonathan U. Peled, David J. Chung, Gunjan L. Shah, Marissa L. Buchan, Brooke Mastrogiacomo, Michael Scordo, Sergio Giralt, Elaina V. Preston, Andrew Lin, Dean Carlow, Andrea Knezevic, Molly Maloy, Ryan Schofield, Heather Landau, Sean M. Devlin
Publikováno v:
Blood. 132:2136-2136
Background: Taste disturbance, or dysgeusia, negatively affects quality of life and may lead to poorer nutritional status after high-dose melphalan and autologous stem cell transplantation (mel-AHCT) for patients with multiple myeloma (MM). Despite i